Some cancer patients hoping to join clinical trials encounter roadblocks. Patients with a prior cancer, for instance, are commonly excluded from enrolling.
A study published in November 2017 in JAMA Oncology found that more than 25 percent of newly diagnosed cancer patients ages 65 and older and 11 percent of those ages 20 to 64 are facing cancer for at least the second time.
A study published in November 2017 in JAMA Oncology found that more than 25 percent of newly diagnosed cancer patients ages 65 and older and 11 percent of those ages 20 to 64 are facing cancer for at least the second time.
The results indicate there could be “an enormous group of patients who are not afforded the opportunity to be able to participate” in trials, says Caitlin Murphy, an epidemiologist at the University of Texas Southwestern Medical Center in Dallas and a study author.
The study used data from the Surveillance, Epidemiology and End Results (SEER) registries on 740,990 Americans newly diagnosed with cancer between 2009 and 2013. The SEER registries contain information on cancer cases in regions of the U.S. and provide insight into cancer statistics in the country as a whole. Patients were defined as having had a prior cancer if they had a separate primary cancer in their history. Recurrence of a previously diagnosed cancer was not considered to be a second cancer.
No comments:
Post a Comment